![](https://researchresearch-news-wordpress-media-live.s3.eu-west-1.amazonaws.com/2022/11/test_tubes_declining-738x443.jpg)
Image: Westend61, via Getty Images
European pharmaceutical group warns that EU policymakers’ efforts to address issues fall “well short”
Europe’s share of the global investment in pharmaceutical R&D has shrunk, putting the bloc even further behind the US, an industry group has warned.
Pharmaceutical R&D expenditure in the US exceeded that in Europe by more than €20 billion ($20bn) in 2020, and the gap between the two has widened from just €2bn 20 years ago, the report from the European Association of Pharmaceutical Industries and Associations (Efpia) notes.